X

MEMBER SPACE Login

"In accordance with the General European Regulation on the protection of individuals with regard to the processing of personal data and on the free movement of such data (RGPD) and the "Data Protection Act" of 6 January 1978 as amended, you have the right to access, rectify, oppose, delete (or "right to oblivion") or limit the processing of your personal data. You also have the right to withdraw your consent at any time by contacting XXXX . Finally, you have the possibility to lodge a complaint with a supervisory authority".

    • Make a donation
    • English
      • French
LungO2
  • Lung O2
    • Presentation of LUNG innOvatiOn
    • Action plan
    • LUNG O2
      Cluster Members
  • News and
    highlights
  • Respiratory diseases
    • Respiratory diseases
  • Clinical Research
  • Projets
  • Training
  • BREATHE
  • COLT Project
  • MELROSE Project
  • HAP² Project
  • PRELUD Project
  • NaRacAS Project

Pages

  • Action plan
  • BREATHE
  • Clinical Research
  • COLT Project
  • Contact us
  • Event &
    highlights
  • HAP² Project
  • Legal notices
  • LUNG O2
    Cluster Members
  • MELROSE Project
  • Member’s area
  • NaRacAS Project
  • News and
    highlights
  • PRELUD Project
  • Presentation of LUNG innOvatiOn
  • Privacy policy page
  • Project &
    Highlights
  • Promoting Nantes respiratory research worldwide
  • Publication
  • Publications &
    Highlights
  • Respiratory diseases
  • Training

Posts by category

  • Category: Event
    • 500th lung transplant in Nantes
    • Development of Mint, the application that takes care of your lungs
    • Sophie Brouard receive the Innovation Medal 2020 from CNRS
  • Category: News
    • A new collaborative article from the LUNG O2 network!
    • Dr. Elvire Pons-Tostivint wins the Alain Depierre Research Award 2021
    • Focus on the Cystic Fibrosis Resource and Competence Centres (CRCM) in Nantes
    • FIRST GENERAL RESPIRATORY HEALTH ASSESSMENT
    • Research on air quality awarded at the 39th University Conference on Civil Engineering
    • Third cluster Newsletter
    • Third Cluster Newsletter
    • The air quality index changed on January 4, 2021.
    • Second Cluster Newsletter
    • First patient in the A2 cohort of the PDC*line Pharma Phase I/II trial at our Clinical Research Center
    • Presentation of the Indoor Environmental Medical Advisor position
    • First Cluster Newsletter
  • Category: Publication
    • Targeting the interleukin‐7 receptor alpha by an anti‐CD127 monoclonal antibody improves allergic airway inflammation in mice
    • Pneumocystis after lung transplantation: A multi-center retrospective study
    • Le ciblage du récepteur Alpha de l’interleukine-7 par un anticorps monoclonal anti-CD127 améliore l’inflammation allergique des voies aériennes chez la souris
    • Pneumocystose après transplantation pulmonaire : Une étude rétrospective multicentrique

Agenda

  • Second summer school of the LUNG innOvatiOn cluster
  • First LUNG O2 Summer School, 1 July 2021
  • Environment, Mobility, Health Conference - Monday, March 22, 2021
  • Postponement of the Advanced Practice Symposium for nurses

Projet

  • 10 years of COLT

Domaine

  • Addressing ethical and sex gender issues
  • Emergence of new technologies for e-Health
  • Organizing respiratory research on the territory
  • Precision medicine

Témoignage

  • les infections pulmonaires à MNT
  • L'asthme sévère
  • Le syndrome de Birt-Hogg Dubé (BHD)
To contact us
LungO2
LUNG 02

Cluster Coordinator

CHU of Nantes

+(33)02 44 76 85 96

Contact us by mail

LungO2 LungO2
Newsletter Inscription

Stay informed and subscribe to our newsletter

    LungO2
    LungO2
    LungO2
    LungO2
    LungO2
    • Sitemap
    • Privacy policy page
    • Legal notices
    • Kalélia Agency